Combination Chemotherapy and Celecoxib in Treating Patients With Advanced Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Celecoxib may stop the growth of tumor cells by stopping blood flow
to the tumor. Combining celecoxib with combination chemotherapy may kill more tumor cells.
PURPOSE: This phase I/II trial is studying the side effects and best dose of irinotecan and
docetaxel when given together with celecoxib and to see how well they work in treating
patients with advanced non-small cell lung cancer.